Randall B. Brenner, Chief Development & Regulatory at Paratek Pharmaceuticals, Inc. (PRTK), sold 39,216 shares at $2.66 ($104K) on 2022-08-09, disclosed to the SEC on 2022-08-10.
Open-market sale of $104k PRTK by Chief Development & Regulatory. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.66 | 19,608 | $52K | 50.0% |
| 2 | $2.66 | 19,608 | $52K | 50.0% |
| Total | $2.66 avg | 39,216 | $104K | 100% |
| Filing → |
| PRTK | SELL | 2022-12-14 | $58K | — | Filing → |
| PRTK | SELL | 2022-11-01 | $12K | — | Filing → |
| PRTK | SELL | 2021-12-15 | $188K | — | Filing → |